Anticoagulation for Aortic Bioprosthesis (ANTIPRO)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT03807921
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Sponsor
- Instituto Nacional de Cirugia Cardiaca, Uruguay
- Registry
-
NCT03807921
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Uruguay
- Registry status
- Completed
Technical summary
Registry record NCT03807921. Randomized; single masking; primary purpose treatment. Start 2019-01-01 (actual); primary completion 2019-12-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Anticoagulation for Aortic Bioprosthesis (ANTIPRO)
- Condition
- Aortic Valve Stenosis
- Condition
- Aortic Valve Disease
- Condition
- Aortic Valve Insufficiency
- Condition
- Aortic Valve Regurgitation
- Intervention (Drug)
- Warfarin
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Instituto Nacional de Cirugia Cardiaca, Uruguay
- Collaborator
- Universidad de la Republica
Record details
- Record id
cardio:ct-nct03807921- Content hash
aaa4e0d74fca3ae275bd635ded7a6ed2b2503172d72f1e971cc9049805c21fa0